Shu‐Yuan Cheng

550 citations
33 papers · 329 indexed · h-index 11
Topics
Bioactive Compounds and Antitumor Agents (8 papers)Cancer therapeutics and mechanisms (7 papers)Metal complexes synthesis and properties (5 papers)
Partner nations
United StatesChinaSpain

In The Last Decade

Shu‐Yuan Cheng

28 papers receiving 324 citations

Peers

Shu‐Yuan Cheng
Comparison fields: 5 of 80
  • Molecular Biology 141
  • Toxicology 70
  • Organic Chemistry 62
  • Oncology 48
  • Inorganic Chemistry 44
Replace Zhi-Qing Ma with:
Zhi-Qing Ma China
Arash Mirzahosseini Hungary
Matic Pavlin Italy
William C. Putnam United States
Hasan Y. Alniss United Arab Emirates
Shannon D. Zanatta Australia
Laurent Gavara France
Aldo Feriani Italy
Congcong Wang China
Arthur Y. Shaw United States
Shu‐Yuan Cheng relative to Zhi-Qing Ma China Zhi-Qing Ma's profile →
Citations per field
00.5×11×
Zhi-Qing Ma · 1×
Citations per year

Countries citing papers authored by Shu‐Yuan Cheng

Since Specialization
Citations

This map shows the geographic impact of Shu‐Yuan Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu‐Yuan Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu‐Yuan Cheng more than expected).

Fields of papers citing papers by Shu‐Yuan Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu‐Yuan Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu‐Yuan Cheng. The network helps show where Shu‐Yuan Cheng may publish in the future.

Co-authorship network of co-authors of Shu‐Yuan Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Shu‐Yuan Cheng. A scholar is included among the top collaborators of Shu‐Yuan Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu‐Yuan Cheng. Shu‐Yuan Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 0
3 0
4 1
5 2
6 2
7 0
8 6
9 2
10 38
11 10
12 9
13 6
14 1
15 23
16 10
17 24
18 6
19 16
20 2

About Shu‐Yuan Cheng

Shu‐Yuan Cheng is a scholar working on Toxicology, Behavioral Neuroscience and Oncology, having authored 33 papers that have together received 329 indexed citations. Recurring topics across this work include Bioactive Compounds and Antitumor Agents (8 papers), Cancer therapeutics and mechanisms (7 papers) and Metal complexes synthesis and properties (5 papers). The work is most often cited by research in Toxicology (70 citations), Inorganic Chemistry (44 citations) and Pollution (30 citations). Shu‐Yuan Cheng has collaborated with scholars based in United States, China and Spain. Frequent co-authors include Marta Concheiro, Élise Champeil, Guoqi Zhang, Manuel M. Paz, Lei Xie, Annie Wang, Hansaim Lim, Haisu Zeng, Kymry T. Jones and Maarten E. A. Reith. Their work appears in journals such as Biochemistry, New Phytologist and Biophysical Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026